
FDA approves new weight loss drug, first since 2014
Fox News
The Food and Drug Administration (FDA) on Friday approved a weight loss drug for overweight or obese adults, marking the first such authorization since 2014.
The drug works by mimicking the glucagon-like peptide-1 hormone which targets areas of the brain that helps regulate appetite and food intake. The FDA warned that it should not be used in combination with other semaglutide-containing products, other GLP-1 receptor agonists, or other weight loss products including herbal products, over-the-counter drugs or prescription drugs. The dosage is meant to be increased gradually over 16 to 20 weeks to 2.4 mg once weekly to reduce gastrointestinal side effects.More Related News

NASA begins infrastructure overhaul under Isaacman as Trump pushes ambitious space exploration goals
NASA Administrator Jared Isaacman demolish facilities Alabama Marshall Space Flight Center Saturday as space agency modernizes infrastructure under new leadership.












